- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
ALNEV
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Neovacs S.A. · Healthcare · Biotechnology
Latest close
1.24 EUR
69.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -86.2% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned 69.9%, after a 2.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
34
out of 100
Latest Close
1.24 EUR
7 Aug 2026
1W Return
69.9%
latest completed week
4W Return
2.1%
short-term follow-through
12W Return
-38.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
5.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 10.34% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
69.9%
Latest completed week; four-week move 2.1%.
Indicator stack
0/91
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 10.34%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -86.2% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned 69.9%, after a 2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 5.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.00
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.1% over four weeks, -38.0% over 12 weeks, and -100.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.61Latest activity-pressure read.
Pressure change370.6%Four-week change in activity pressure.
Leadership-99.86Latest relative-leadership reading.
RS change0.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-100.0%Distance below the 52-week high.
13-week volatility22.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher2 of 2614 weeks finished lower.
Best week+69.9%Week of 7 Aug.
Worst week-50.0%Week of 1 May.
Latest week+69.9%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains0
Flat weeks10
Modest losses1
Sharp losses13
Recent vol22.7%13-week weekly-return volatility.
Base vol18.5%52-week weekly-return volatility.
Up/down split5/37Count of positive and negative weeks in the 52-week window.
Average skew18.6% / -21.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank27 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Biotechnology
4-week rank14 / 33
Group average4.5%
Trend breadth27.3%
Trend27.3%active weekly trend signals
MD36.4%positive activity pressure
RS21.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis26/100Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 10.34%Next-week expectancy is negative with a 10.34% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Neovacs SA (ALNEV.PA) Stock Price, News & Analyst Forecast Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.24 EUR | 69.9% | 8.95 EUR | 1,682,598 EUR | 0.61 | -99.86 | 170.4K | Off |
| 31 Jul 2026 | 0.73 EUR | -1.6% | 11.31 EUR | 1,752,406 EUR | 0.42 | -99.93 | 28.0K | Off |
| 24 Jul 2026 | 0.74 EUR | -17.6% | 14.22 EUR | 1,831,060 EUR | 0.37 | -99.94 | 33.0K | Off |
| 17 Jul 2026 | 0.90 EUR | -25.9% | 17.40 EUR | 1,993,945 EUR | 0.28 | -99.94 | 47.3K | Off |
| 10 Jul 2026 | 1.21 EUR | -5.2% | 20.37 EUR | 2,186,893 EUR | 0.13 | -99.94 | 39.4K | Off |
| 3 Jul 2026 | 1.28 EUR | -15.8% | 23.69 EUR | 2,430,483 EUR | -0.01 | -99.95 | 14.3K | Off |
| 26 Jun 2026 | 1.52 EUR | -24.0% | 28.25 EUR | 2,815,034 EUR | -0.05 | -99.95 | 4.3K | Off |
| 19 Jun 2026 | 2.00 EUR | 0.0% | 33.80 EUR | 3,167,598 EUR | 0.12 | -99.94 | 8.8K | Off |
| 12 Jun 2026 | 2.00 EUR | 0.0% | 41.47 EUR | 3,645,739 EUR | 0.28 | -99.95 | 9.9K | Off |
| 5 Jun 2026 | 2.00 EUR | 0.0% | 50.37 EUR | 4,107,278 EUR | 0.51 | -99.96 | 14.1K | Off |
| 29 May 2026 | 2.00 EUR | 0.0% | 62.53 EUR | 4,562,406 EUR | 0.71 | -99.96 | 16.1K | Off |
| 22 May 2026 | 2.00 EUR | 0.0% | 76.47 EUR | 4,562,509 EUR | 0.71 | -99.97 | 16.3K | Off |
| 15 May 2026 | 2.00 EUR | 0.0% | 99.27 EUR | 4,562,662 EUR | 0.73 | -99.97 | 42.9K | Off |
| 8 May 2026 | 2.00 EUR | 0.0% | 127.0 EUR | 4,562,765 EUR | 0.69 | -99.98 | 29.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.